| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.30▼ | 1.31▼ | 1.30▲ | 1.25▲ | 1.48▼ |
| MA10 | 1.30▼ | 1.30▲ | 1.28▲ | 1.19▲ | 1.78▼ |
| MA20 | 1.31▼ | 1.27▲ | 1.27▲ | 1.43▼ | 2.23▼ |
| MA50 | 1.29▲ | 1.26▲ | 1.20▲ | 1.80▼ | 3.94▼ |
| MA100 | 1.27▲ | 1.18▲ | 1.27▲ | 2.34▼ | 11.27▼ |
| MA200 | 1.27▲ | 1.30▲ | 1.54▼ | 2.92▼ | 25.36▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.003▲ | 0.001▲ | 0.017▲ | 0.062▲ |
| RSI | 48.206▼ | 56.618▲ | 57.395▲ | 39.497▼ | 32.359▼ |
| STOCH | 36.111 | 75.314 | 82.646▲ | 60.125 | 15.721▼ |
| WILL %R | -66.667 | -26.923 | -26.923 | -60.563 | -85.417▼ |
| CCI | -108.772▼ | 48.128 | 83.992 | 18.824 | -137.725▼ |
|
Monday, April 14, 2025 05:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
|
Saturday, April 05, 2025 05:00 PM
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been assigned an average recommendation of “Hold” from the nine ratings firms that are presently covering the ...
|
|
Tuesday, April 01, 2025 10:30 PM
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/04/25 | 1.25 | 1.34 | 1.23 | 1.29 | 889,002 |
| 16/04/25 | 1.26 | 1.285 | 1.20 | 1.26 | 985,459 |
| 15/04/25 | 1.20 | 1.315 | 1.20 | 1.27 | 690,189 |
| 14/04/25 | 1.27 | 1.27 | 1.185 | 1.22 | 639,180 |
| 11/04/25 | 1.14 | 1.25 | 1.09 | 1.23 | 844,258 |
| 10/04/25 | 1.17 | 1.1865 | 1.055 | 1.13 | 687,842 |
| 09/04/25 | 1.03 | 1.24 | 1.01 | 1.17 | 1,201,532 |
| 08/04/25 | 1.19 | 1.23 | 1.02 | 1.04 | 896,937 |
| 07/04/25 | 1.171 | 1.20 | 1.085 | 1.16 | 991,590 |
| 04/04/25 | 1.25 | 1.28 | 1.13 | 1.17 | 1,275,800 |
|
|
||||
|
|
||||
|
|